Style | Citing Format |
---|---|
MLA | M Tahmasbi MOHAMMAD, et al.. "Nobiletin Can Play a Role in Improving Inflammation by Inhibiting the Nf-Kb and Mapk Pathways in Muscle Cells." Journal of Diabetes and Metabolic Disorders, vol. 24, no. 2, 2025, pp. -. |
APA | M Tahmasbi MOHAMMAD, A Karimpour AMIN, M Rashidi MOJTABA, M Zangooei MOHAMMAD, A Khedri AZAM, G Panahi GHODRATOLLAH (2025). Nobiletin Can Play a Role in Improving Inflammation by Inhibiting the Nf-Kb and Mapk Pathways in Muscle Cells. Journal of Diabetes and Metabolic Disorders, 24(2), -. |
Chicago | M Tahmasbi MOHAMMAD, A Karimpour AMIN, M Rashidi MOJTABA, M Zangooei MOHAMMAD, A Khedri AZAM, G Panahi GHODRATOLLAH. "Nobiletin Can Play a Role in Improving Inflammation by Inhibiting the Nf-Kb and Mapk Pathways in Muscle Cells." Journal of Diabetes and Metabolic Disorders 24, no. 2 (2025): -. |
Harvard | M Tahmasbi MOHAMMAD et al. (2025) 'Nobiletin Can Play a Role in Improving Inflammation by Inhibiting the Nf-Kb and Mapk Pathways in Muscle Cells', Journal of Diabetes and Metabolic Disorders, 24(2), pp. -. |
Vancouver | M Tahmasbi MOHAMMAD, A Karimpour AMIN, M Rashidi MOJTABA, M Zangooei MOHAMMAD, A Khedri AZAM, G Panahi GHODRATOLLAH. Nobiletin Can Play a Role in Improving Inflammation by Inhibiting the Nf-Kb and Mapk Pathways in Muscle Cells. Journal of Diabetes and Metabolic Disorders. 2025;24(2):-. |
BibTex | @article{ author = {M Tahmasbi MOHAMMAD and A Karimpour AMIN and M Rashidi MOJTABA and M Zangooei MOHAMMAD and A Khedri AZAM and G Panahi GHODRATOLLAH}, title = {Nobiletin Can Play a Role in Improving Inflammation by Inhibiting the Nf-Kb and Mapk Pathways in Muscle Cells}, journal = {Journal of Diabetes and Metabolic Disorders}, volume = {24}, number = {2}, pages = {-}, year = {2025} } |
RIS | TY - JOUR AU - M Tahmasbi MOHAMMAD AU - A Karimpour AMIN AU - M Rashidi MOJTABA AU - M Zangooei MOHAMMAD AU - A Khedri AZAM AU - G Panahi GHODRATOLLAH TI - Nobiletin Can Play a Role in Improving Inflammation by Inhibiting the Nf-Kb and Mapk Pathways in Muscle Cells JO - Journal of Diabetes and Metabolic Disorders VL - 24 IS - 2 SP - EP - PY - 2025 ER - |